Zydus Wellness Limited has accepted the resignation of Mr. Lalit Ahuja from the position of Head – Sales (India & ISC), effective from the close of business hours on July 3, 2026. The resignation marks the departure of a senior management official who oversaw sales operations in India and the Indian Subcontinent (ISC). Mr. Ahuja stated that the decision was driven by a desire to pursue better career opportunities outside the organization.

The company informed the stock exchanges regarding the personnel change under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was also made in accordance with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The filing confirmed that Mr. Ahuja has been relieved of his duties effective July 3, 2026.

In his resignation letter addressed to Mr. Tarun Arora, Chief Executive Officer & Whole Time Director, Mr. Ahuja reflected on his tenure, noting his involvement in the organization's transformation over the past decade. He expressed satisfaction with the achievements during his tenure and gratitude towards the leadership for their support. He requested that his last working date be considered as July 3, 2026, to facilitate a smooth transition.

The following table summarizes the key details of the cessation:

The resignation was formally signed by Mr. Nandish P. Joshi, Company Secretary & Compliance Officer of Zydus Wellness Limited. The company has attached the resignation letter and requisite details as annexures to the regulatory filing.

Zydus Wellness Limited has appointed Dr. Shyam Ramakrishnan as its Chief Scientific Officer, effective July 1, 2026, strengthening its senior management leadership. The appointment follows a recommendation by the Nomination and Remuneration Committee and was approved by the Board of Directors. Dr. Ramakrishnan joins the organization on a full-time contract basis, bringing extensive expertise in translational science and innovation platform development.

The disclosure was made to the exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company submitted the requisite details as stipulated by the SEBI Master Circular dated January 30, 2026. The appointment is effective immediately from the start of July 2026.

Dr. Shyam Ramakrishnan holds a PhD in Biological Chemistry & Genetics from the University of Texas. He has completed postdoctoral fellowships at Harvard Medical School and Hoffmann-La Roche. His academic background provides a strong foundation for his role in leading scientific strategy at zydus wellness .

Professional Background

Dr. Ramakrishnan brings over 25 years of experience across nutrition, dietary supplements, beauty, personal care, and functional foods. His career spans leadership roles in major organizations across the US, India, Southeast Asia, and other international markets. He has specialized in translational science, clinical research, bioinformatics, and innovation platform development.

Prior to this appointment, he served in key leadership positions with Hill's Pet Nutrition, The Himalaya Drug Company, ITC Ltd., and Amway in the United States, Southeast Asia, and Brazil. His experience includes leading large cross-functional teams and driving innovation in the consumer health and wellness sectors.

Appointment Details